Protagonist Therapeutics (PTGX) – Hot New Coverage
-
Jefferies Assumes Protagonist Therapeutics (PTGX) at Buy, Sees 59% Upside
-
UPDATE: Piper Sandler Starts Protagonist Therapeutics (PTGX) at Overweight, Sees 168% Upside
-
-
-
-
-
-
Back to PTGX Stock Lookup